CM
BIOS

Cohanzick Management’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

Cohanzick Management’s Portfolio BIOS Stock Details BIOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-30,182
Closed -$315K – 93
2023
Q1 		$315K Hold
30,182
– – 0.25% 52
2022
Q4 		$310K Buy
30,182
+10,518
+53% +$107K 0.09% 119
2022
Q3 		$197K Sell
19,664
-336
-2% -$3.36K 0.05% 181
2022
Q2 		$201K Buy
+20,000
New +$199K 0.06% 190

Other funds holding BIOS

WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $2.18B AUM 13.58% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
QL
Quarry LP New York $1.2B AUM 47.63% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Cohanzick Management's BIOS Position: Q2 2023 in Review

Cohanzick Management sold out of BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) in Q2 2023, closing a stake of 30,182 shares — an estimated $315K sold.

Cohanzick Management first reported a position in BIOS in Q2 2022 and held it in 4 quarters. The position peaked at $315K in Q1 2023. 32 funds tracked by Wall St. Rank hold BIOS as of Q2 2023.

  • Cohanzick Management reported no remaining BioPlus Acquisition Corp. Class A Ordinary Shares position as of Q2 2023 after selling out during the quarter.
  • Cohanzick Management sold 30,182 BioPlus Acquisition Corp. Class A Ordinary Shares shares in Q2 2023, an estimated $315K.
  • Cohanzick Management first reported a position in BioPlus Acquisition Corp. Class A Ordinary Shares in Q2 2022 and held it in 4 quarters.
  • Cohanzick Management's BioPlus Acquisition Corp. Class A Ordinary Shares position peaked at $315K in Q1 2023.
  • 32 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Class A Ordinary Shares as of Q2 2023.

Based on Cohanzick Management's 13F filing for Q2 2023, filed 14 Aug 2023.